We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-3.74%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$309B
AUM Growth
-$29.4B
Cap. Flow
-$6.3B
Cap. Flow %
-2.04%
Top 10 Hldgs %
22.53%
Holding
3,477
New
138
Increased
1,588
Reduced
1,481
Closed
89

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$712M
2
META icon
Meta Platforms (Facebook)
META
+$565M
3
PYPL icon
PayPal
PYPL
+$556M
4
MS icon
Morgan Stanley
MS
+$541M
5
PFE icon
Pfizer
PFE
+$388M

Sector Composition

Rank Sector Weight
1 Technology 24.81%
2 Financials 12.45%
3 Healthcare 12.44%
4 Consumer Discretionary 11.85%
5 Industrials 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPB icon
2501
Turning Point Brands
TPB
$1.74B
$1.91M ﹤0.01%
59,761
-1,349
-2% -$45.8K
WTTR icon
2502
Select Water Solutions
WTTR
$2.61B
$1.91M ﹤0.01%
210,073
+2,397
+1% +$18.7K
STGW icon
2503
Stagwell
STGW
$2.24B
$1.91M ﹤0.01%
258,367
-21,770
-8% -$163K
INBX
2504
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.9M ﹤0.01%
83,019
+1,019
+1% +$26K
ESPR
2505
DELISTED
Esperion Therapeutics
ESPR
$1.89M ﹤0.01%
340,899
+261,772
+331% +$1.12M
BOC icon
2506
Boston Omaha
BOC
$436M
$1.88M ﹤0.01%
65,167
+741
+1% +$20.2K
NAGE
2507
Niagen Bioscience
NAGE
$247M
$1.88M ﹤0.01%
762,027
-17,941
-2% -$49K
CRGY icon
2508
Crescent Energy
CRGY
$3.82B
$1.88M ﹤0.01%
108,213
+25,515
+31% +$377K
FISI icon
2509
Financial Institutions
FISI
$821M
$1.85M ﹤0.01%
58,570
+572
+1% +$18.4K
LFST icon
2510
Lifestance Health
LFST
$4.14B
$1.85M ﹤0.01%
207,271
+68,449
+49% +$601K
MCRB icon
2511
Seres Therapeutics
MCRB
$48.4M
$1.85M ﹤0.01%
12,695
+653
+5% +$100K
FOSL icon
2512
Fossil Group
FOSL
$318M
$1.84M ﹤0.01%
177,352
-9,868
-5% -$112K
CIR
2513
DELISTED
CIRCOR International, Inc
CIR
$1.84M ﹤0.01%
65,162
+8,139
+14% +$216K
LTH icon
2514
Life Time Group Holdings
LTH
$9.79B
$1.84M ﹤0.01%
126,581
+1,422
+1% +$21.6K
NAPA
2515
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$1.84M ﹤0.01%
104,645
+15,033
+17% +$294K
PETS icon
2516
PetMed Express
PETS
$42.3M
$1.83M ﹤0.01%
66,348
+740
+1% +$19.2K
CSTR
2517
DELISTED
CapStar Financial Holdings, Inc
CSTR
$1.83M ﹤0.01%
85,507
-4,225
-5% -$90.4K
CLAR icon
2518
Clarus
CLAR
$143M
$1.83M ﹤0.01%
76,795
-19,229
-20% -$445K
VXRT
2519
DELISTED
Vaxart
VXRT
$1.83M ﹤0.01%
365,479
+4,475
+1% +$22.7K
TBPH icon
2520
Theravance Biopharma
TBPH
$877M
$1.81M ﹤0.01%
186,906
+22,116
+13% +$217K
EBF icon
2521
Ennis
EBF
$564M
$1.79M ﹤0.01%
97,293
+11,720
+14% +$220K
TPC
2522
Tutor Perini Cor
TPC
$5.21B
$1.79M ﹤0.01%
175,343
+20,819
+13% +$233K
KRO icon
2523
KRONOS Worldwide
KRO
$989M
$1.79M ﹤0.01%
112,984
-106,768
-49% -$1.59M
NGMS
2524
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$1.79M ﹤0.01%
115,836
-12,114
-9% -$254K
GOSS icon
2525
Gossamer Bio
GOSS
$87M
$1.78M ﹤0.01%
203,936
-3,018
-1% -$29.1K

Similar funds

Nuveen's Q1 2022 Portfolio in Review

As of Q1 2022, Nuveen held 3,477 positions worth $309B, down 8.7% from $338B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q1 2022 filing shows 138 new, 1,588 increased, 1,481 reduced and 89 closed positions. Its largest new stake was Constellation Energy: 1,208,173 shares worth $59.5M. The largest sale was Qualcomm, an estimated $712M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q1 2022 buy was Constellation Energy: 1,208,173 shares worth $59.5M.
  • Nuveen added most to Advanced Micro Devices in Q1 2022, an estimated $949M increase.
  • Nuveen's biggest Q1 2022 reduction was Qualcomm, cutting an estimated $712M.
  • Nuveen fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $264M.
  • Nuveen's ten largest holdings make up 23% of its $309B portfolio in Q1 2022.
  • Nuveen opened 138 new positions and closed 89 in Q1 2022.
  • Nuveen's portfolio value fell 8.7% quarter-over-quarter to $309B.

Based on Nuveen's 13F filing for Q1 2022, filed 16 May 2022.